Global Intraosseous Devices Market Set for Significant Growth, Projected to Reach USD 938.6 Million by 2035 Driven by Growing Demand and Technological Advancements. The U.S. leads the intraosseous ...
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery platform, today ...
An extravasation risk rating system introduced for all IV medicines has led to increased patient safety at Birmingham Women’s and Children’s NHS Foundation Trust.